Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A British Thoracic Oncology Group Phase III Trial of Gemcitabine Plus Cisplatin at 80mg/m Versus Gemcitabine Plus Carboplatin At 50 mg/m Versus Gemcitabine Plus Carboplatin AUC 6 in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)

NCT00112710 is registered in ClinicalTrials.gov with University Hospital Birmingham as lead sponsor.

NCT NCT00112710
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00112710 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A British Thoracic Oncology Group Phase III Trial of Gemcitabine Plus Cisplatin at 80mg/m Versus Gemcitabine Plus Carboplatin At 50 mg/m Versus Gemcitabine Plus Carboplatin AUC 6 in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)
Lead sponsor
University Hospital Birmingham
Phase
Phase 3
Overall status
Unknown status
Start date
March 31, 2005
Completion date
Not reported
Enrollment
1,350 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer